Blogs

Blog post list

• How the faecal immunochemical test is changing bowel cancer referrals and what it tells us about the power of NICE guidance

  Learn how NICE's healthtech guidance is accelerating NHS adoption of a simple bowel cancer test, preventing 140,000 unnecessary urgent referrals a year while keeping cancer detection rates stable.

• Why flexibility is built into everything we do at NICE Advice

  No two products are the same, so no two NICE Advice projects should be either. Andrew Walsh explains how NICE Advice adapts its services to fit your situation.

• Our evidence standards framework for digital care technologies

  NICE has been commissioned by the Department of Health and Social Care and NHS England to adapt the evidence standards framework for digital health technologies to support evidence-based decision making for digital care technologies used in adult social care.

• MHRA-NICE pathway opens for business – everything you need to know to get started

  Learn how the MHRA and NICE are getting medicines to patients 3 to 6 months sooner by delivering same time decisions on licensing and value.

• Better data for better decisions

  Sophie Cooper, senior scientific adviser in NICE’s science policy team, explains the importance of the recently published EQ-5D-5L value set and how it has the potential to help us decide if new treatments offer good value for money for the NHS.